Search alternatives:
significant orders » significant others (Expand Search), significant burdens (Expand Search), significant degs (Expand Search)
linear decrease » linear increase (Expand Search)
inter decrease » water decreases (Expand Search), teer decrease (Expand Search), step decrease (Expand Search)
orders based » disorders based (Expand Search), models based (Expand Search), areas based (Expand Search)
Showing 61 - 80 results of 12,334 for search '(( significant orders based ) OR ( significant ((inter decrease) OR (linear decrease)) ))', query time: 0.60s Refine Results
  1. 61
    Multiplication rate of J774 and RAW cells in relation to the intracellular growth of ITMAP-263 (not showing significant intracellular multiplication in PECs) and LEM3049 (showing rapid intracellular replication in PECs).

    Multiplication rate of J774 and RAW cells in relation to the intracellular growth of ITMAP-263 (not showing significant intracellular multiplication in PECs) and LEM3049 (showing r... by Sarah Hendrickx (321143)

    Published 2019
    Save to List
    Saved in:
  2. 62
    Trends in the days of sulfamethoxazole-trimethoprim therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of sulfamethoxazole-trimethoprim therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Save to List
    Saved in:
  3. 63
    Trends in in-hospital mortality by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in in-hospital mortality by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4). by Naoya Itoh (6029276)

    Published 2023
    Save to List
    Saved in:
  4. 64
    Trends in the days of cefalexin therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of cefalexin therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Save to List
    Saved in:
  5. 65
    Trends in the days of quinolone therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of quinolone therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Save to List
    Saved in:
  6. 66
    Trends in the length of hospital stay by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in the length of hospital stay by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4). by Naoya Itoh (6029276)

    Published 2023
    Save to List
    Saved in:
  7. 67
    Trends in the days of macrolides therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of macrolides therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Save to List
    Saved in:
  8. 68
    Trends in the days of amoxicillin and amoxicillin-clavulanate therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of amoxicillin and amoxicillin-clavulanate therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Save to List
    Saved in:
  9. 69
    Trends in the days of third-generation cephalosporin therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of third-generation cephalosporin therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Save to List
    Saved in:
  10. 70
    Trends in the incidence of <i>Clostridioides difficile</i> infection (CDI) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in the incidence of <i>Clostridioides difficile</i> infection (CDI) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phas... by Naoya Itoh (6029276)

    Published 2023
    Save to List
    Saved in:
  11. 71
    Trends in the incidence of extended-spectrum β-lactamase (ESBL)- producing Enterobacteriaceae per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in the incidence of extended-spectrum β-lactamase (ESBL)- producing Enterobacteriaceae per 1000 patients, by month, during the pre-intervention period (Phase 1) and interven... by Naoya Itoh (6029276)

    Published 2023
    Save to List
    Saved in:
  12. 72
    Trends in the incidence of methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in the incidence of methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional pe... by Naoya Itoh (6029276)

    Published 2023
    Save to List
    Saved in:
  13. 73
    Trends in the incidence of penicillin-resistant <i>Streptococcus pneumoniae</i> (PRSP) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in the incidence of penicillin-resistant <i>Streptococcus pneumoniae</i> (PRSP) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional... by Naoya Itoh (6029276)

    Published 2023
    Save to List
    Saved in:
  14. 74
    Trends in the incidence of resistant <i>Haemophilus influenzae</i> per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in the incidence of resistant <i>Haemophilus influenzae</i> per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).... by Naoya Itoh (6029276)

    Published 2023
    Save to List
    Saved in:
  15. 75
    Zero order correlations–male candidate.

    Zero order correlations–male candidate. by Cassandra L. Crone (12822335)

    Published 2022
    Save to List
    Saved in:
  16. 76
    Zero order correlations–female candidate.

    Zero order correlations–female candidate. by Cassandra L. Crone (12822335)

    Published 2022
    Save to List
    Saved in:
  17. 77
    Coefficients of the reduced linear regression model without multicollinearity.

    Coefficients of the reduced linear regression model without multicollinearity. by Dania AL-Najjar (11840857)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  18. 78
    Flowchart of neural network and linear regression prediction model.

    Flowchart of neural network and linear regression prediction model. by Dania AL-Najjar (11840857)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  19. 79
    Coefficients of the reduced linear regression model without multicollinearity.

    Coefficients of the reduced linear regression model without multicollinearity. by Dania AL-Najjar (11840857)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  20. 80
    Significant differences in cord blood metabolites between subsequently allergic and non-allergic children based on diagnosis of allergy at different ages.

    Significant differences in cord blood metabolites between subsequently allergic and non-allergic children based on diagnosis of allergy at different ages. by Alastair B. Ross (461945)

    Published 2021
    Save to List
    Saved in:

Search Tools: